ARCHIVES

FDA Advisory Committee Recommends Approval Of Ifosfamide as Third Line Therapy For Testicular Cancer

This article is from The Cancer Letter archive.

Vol. 14 No. 18 | April 29, 1988

Download PDF Visit The Full Archive

Related Articles

NCI-Approved Protocols Listed

December 26, 2003

Trombold Tells How Scripps Raises Money for Cancer Center, Gets Independent From “Whiny Administrator”

April 5, 1985

Taxotere Added To Regimen Improves Survival, Study Finds

July 29, 2005

In Myriad Case, the Supreme Court Hears About Tree Leaves, Baseball and Cookies

April 19, 2013

Physicians Group Makes No “Simple Recommendation” on Mammograms for Women Aged 40-49.

April 6, 2007

In Brief: Raub To Leave NIH For Science Office; Douros Dead At 60; ‘NEJM’ To Publish Aspirin Study

November 29, 1991